https://www.news-medical.net/news/2009/03/11/46787.aspx
Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint
Jun 20, 2019 - Genentech, Inc. and Biogen Idec has announced that a Phase III study of Rituxan (rituximab) plus mycophenolate mofetil (MMF) and corticosteroids in patients...
lupus nephritisstudyrituxanrituximabmisses
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/50242-0109/
50242-0109 Rituxan Hycela - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
rituxanndc
https://www.news-medical.net/news/2006/03/01/16303.aspx
FDA approves Rituxan (Rituximab)
Jun 17, 2019 - Rituxan is the first treatment for RA that selectively targets immune cells known as CD20-positive B-cells. Through this unique mechanism of action, Rituxan...
fda approvesrituxanrituximab